A notable advancement in glucose management is emerging with the release of tirzepatide at a dosage of 45mg. This updated formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://theresaxplj770957.articlesblogger.com/63242992/groundbreaking-introduction-tirzepatide-dose-for-blood-sugar-control